Product Information
CHILDREN IBUPROFEN 100 MG/5 ML is a generic product labeled by Puro Pharma Inc., priced at $0.0332 per ML under NDC 83474000204. Its NADAC has been published 119 times since Jun 26, 2024.
FDA first approved this application on Nov 23, 2018.
Strength
100 mg/5mL
Manufacturer
Puro Pharma Inc.NDC
83474000204
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA210602FDA Approved
11/23/2018
On Market Since
3/28/2024
Pharmacological Classes
Price Statistics
The NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has been published 119 times since Jun 26, 2024, and over the history we have for it it has declined 2.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0332 per ML |
|---|---|
| All-time high | $0.0375 (Sep 11, 2024) |
| All-time low | $0.0314 (Jul 17, 2024) |
| 52-week high | $0.0358 |
| 52-week low | $0.0332 |
| Median price | $0.0348 |
| Average price | $0.0346 |
| Largest weekly change | +19.3% (Aug 21, 2024) |
| Weeks tracked | 119 |
| Tracking since | Jun 26, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the IBUPROFEN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Puro Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
IBUPROFEN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHILDREN IBUPROFEN 100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CHILDREN IBUPROFEN 100 MG/5 ML, manufactured by Puro Pharma Inc., is $0.0332 per ML (NDC 83474000204), effective Sep 30, 2026.
How has the price of CHILDREN IBUPROFEN 100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has declined 2.0%. It has been tracked across 119 weekly CMS publications since Jun 26, 2024.
What are the highest and lowest recorded NADAC prices for CHILDREN IBUPROFEN 100 MG/5 ML?
Since Jun 26, 2024, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has ranged from a low of $0.0314 (Jul 17, 2024) to a high of $0.0375 (Sep 11, 2024), with a median of $0.0348 per ML.
Are there cheaper alternatives to CHILDREN IBUPROFEN 100 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of CHILDREN IBUPROFEN 100 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHILDREN IBUPROFEN 100 MG/5 ML?
CHILDREN IBUPROFEN 100 MG/5 ML (NDC 83474000204) is labeled by Puro Pharma Inc., and CMS classifies it as a generic product.